Optimizing Bispecific Antibody Treatment for Non-Hodgkin Lymphoma: Current Best Practices for Mitigating and Managing Cytokine Release Syndrome (Ask-the-Experts)

September 03, 2025 2:00PM - 3:30PM EDT

Virtual events - 9/3 2-3:30 ET and 9/17 3-4:30 ET

Event Details

Event Date/Time
Wednesday, September 3, 2025
2:00-3:30 PM ET
Audience Event Link: https://event.webcasts.com/starthere.jsp?ei=1718911&tp_key=b05a628c9a

Wednesday, September 17, 2025
3:00-4:30 PM ET
Audience Event Link: https://event.webcasts.com/starthere.jsp?ei=1718914&tp_key=5279da37be

Location
From the convenience of your home or business; accessible via both PC and MAC

Fee
Free. There is no fee for this educational activity.

Type of Activity
Application.

Estimated Time to Complete Activity
90 minutes

Specialty
Hematology-Oncology

Topics
Oncology

Credit Available

Program Overview

The goal of this educational activity is to equip and empower oncology pharmacists, nurse practitioners (NPs), and nurses with the knowledge, competence, and confidence they need to ensure the safe and effective use of bispecific antibodies (BsAbs) for patients with B-cell non-Hodgkin lymphoma, with a particular emphasis on best practice monitoring, mitigation, and collaborative management of BsAb-associated cytokine release syndrome within integrated clinical workflows and logistical frameworks.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  1. Describe the prevalence, practice gaps, and traditional standard of care treatment for B-cell non-Hodgkin lymphoma (B-NHL)
  2. Evaluate the trial evidence and regulatory milestones for CD3xCD20 bispecific antibodies (BsAbs) in B-NHL, with a focus on BsAb-associated cytokine release syndrome (CRS)
  3. Explain the mechanisms involved in hypertriglyceridemic pancreatitis and demonstrate the steps for accurate diagnosis and appropriate treatment.
  4. Design coordinated care plans to monitor, mitigate, and manage CRS, ICANS, and late toxicities in patients receiving BsAbs for B-NHL in accordance with current expert consensus guidance

Agenda

Introduction (5 minutes)
Presentation (70 minutes)
Conclusions & Question & Answer Session (15 minutes)

Faculty

Issam S. Hamadeh, PharmD

Issam S. Hamadeh, PharmD
Clinical Pharmacy Specialist
Memorial Sloan Kettering Cancer Center
New York, NY

Katherine Byar, MSN, APN, BC, BMTCN

Katherine Byar, MSN, APN, BC, BMTCN®
Hematological Malignancy Nurse Practitioner
Oncology/Hematology
Fred & Pamela Buffett Cancer Center
Omaha, Nebraska

Accreditation Statements

PHARMACY

Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council

for Pharmacy Education as a provider of continuing pharmacy education.

UAN: 0430-9999-25-045-L01-P
Credits: 1.5 hour (0.15 ceu)

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Postgraduate Healthcare Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours. Designated contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses pending.

Disclosures of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

How To Earn Credit

Participants must 1) read the learning objectives and faculty disclosures; 2) attend and participate in the live event; and 3) complete the posttest and evaluation form directly after the event with a maximum of within 60 days of attending the live session. To answer the questions, click on your selected choice for each answer then proceed to the next question. Your credit will automatically uploaded to CPE Monitor.

Required Computer Hardware/Software

Please ensure the computer system you plan to use meets the following minimum requirements:

  • Operating System: Windows 98 or higher & Macintosh 2.2 or higher
  • Internet Browser (Mac / Windows): Microsoft Edge, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
  • Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
  • Peripherals: Computer speakers or headphones
  • Monitor Screen Resolution: 320 x 480 or higher
  • Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, & HTML5